Almotriptan

Almotriptan is a selective 5-HT1B/1D receptor agonist (triptan) that constricts cranial blood vessels and inhibits pro-inflammatory neuropeptide release, providing targeted abortive therapy for acute migraine attacks. Simson Pharma's Almotriptan reference standard and impurities support stability-indicating assay work for this migraine-specific therapeutic class.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Almotriptan Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Almotriptan
Almotriptan Malate
Spiroalmotriptan
2-Hydroxyalmotriptan
Almotriptan Dimer Impurity
Almotriptan EP Impurity A
Almotriptan Related Compound B(USP)
Almotriptan EP Impurity E Hydrochloride
Almotriptan EP Impurity E
Almotriptan EP Impurity C
Almotriptan N-Dimer Impurity
Almotriptan Impurity 2 Malate
Almotriptan Isopropyl Impurity
Almotriptan Hydrazine Precursor
N-Dinitroso Almotriptan
Almotriptan Related Compound B (fumarate Salt)
Almotriptan Related Compound C Maleate Salt
Almotriptan Methyl Tetrahydro Indole Impurity
Almotriptan USP Related Compound B Hemifumarate
N-Nitroso Desmethyl Almotriptan impurity
Almotriptan EP Impurity D
Almotriptan N-Dimer
Almotriptan Nitroso Impurity 1
N-Nitroso Almotriptan EP Impurity E
N-Nitroso 2-Hydroxyalmotriptan
1-((4-Nitrobenzyl)sulfonyl)pyrrolidine
Almotriptan N-Isopropyl Impurity

Isotope Labelled Compounds

Almotriptan D6 Maleate